A Pharmacokinetics and Safety Study of Augmentin ES-600 in Children With CAP and ABRS
Condition:   Infections, Bacterial Intervention:   Drug: Augmentin ES Sponsor:   GlaxoSmithKline Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 22, 2022 Category: Research Source Type: clinical trials

Beta-Lactam Containing Regimen for the Shortening of Buruli Ulcer Disease Therapy
Condition:   Buruli Ulcer Interventions:   Drug: Standard [RC8]: rifampicin plus clarithromycin (RC) therapy for 8 weeks.;   Drug: Investigational [RCA4]: standard (RC) plus amoxicillin/clavulanate (A) for 4 weeks. Sponsors:   Fundacion Agencia Aragonesa para la Investigacion y Desarrollo (ARAID);   Universidad de Zaragoza;   Fondation Raoul Follereau;   Université d'Abomey-Calavi;   Instituto de Salud Carlos III;   Fundación Anesvad Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 27, 2021 Category: Research Source Type: clinical trials